Deborah C. Draghi

发表

Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.

A. Evangelista, D. Sahm, C. Thornsberry, 2008, Postgraduate medicine.

Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005

P. Asbell, D. Sahm, N. Brown, 2008, Journal of cataract and refractive surgery.

Clinical Isolates of Streptococcus pneumoniae with Different Susceptibilities to Ceftriaxone and Cefotaxime

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Antimicrobial Agents and Chemotherapy.

Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003

J. Karlowsky, D. Sahm, Mark E. Jones, 2004, Annals of Clinical Microbiology and Antimicrobials.

In Vitro Activity of Tigecycline against Gram-Positive and Gram-Negative Pathogens as Evaluated by Broth Microdilution and Etest

D. Sahm, Deborah C. Draghi, M. Dowzicky, 2008, Journal of Clinical Microbiology.

Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

J. Karlowsky, D. Sahm, Mark E. Jones, 2004, Annals of Clinical Microbiology and Antimicrobials.

In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy

R. Wenzel, J. Karlowsky, D. Sahm, 2003, Antimicrobial Agents and Chemotherapy.

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.

J. Karlowsky, D. Sahm, I. Critchley, 2003, The Journal of antimicrobial chemotherapy.

Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US.

J. Karlowsky, D. Sahm, I. Critchley, 2002, International journal of antimicrobial agents.

In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren.

J. Karlowsky, D. Sahm, I. Critchley, 2002, Diagnostic microbiology and infectious disease.

Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002

J. Karlowsky, J. Bradley, D. Sahm, 2004, Annals of Clinical Microbiology and Antimicrobials.

Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs.

D. Sahm, D. Sheehan, Deborah C. Draghi, 2008, Diagnostic microbiology and infectious disease.

Activities of Faropenem, an Oral β-Lactam, against Recent U.S. Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

Effect of Polysorbate 80 on Oritavancin Binding to Plastic Surfaces: Implications for Susceptibility Testing

D. Sahm, G. Moeck, F. Arhin, 2008, Antimicrobial Agents and Chemotherapy.

1 Effect of Polysorbate-80 on Oritavancin Binding to Plastic Surfaces – 1 Implications for Susceptibility Testing 2 3 4 Running Title : Polysorbate-80 effect on oritavancin binding 5 6 7

D. Sahm, G. Moeck, F. Arhin, 2008 .

Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates

D. Sahm, G. Moeck, F. Arhin, 2009, Antimicrobial Agents and Chemotherapy.

In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.

K. Krause, D. Sahm, C. Thornsberry, 2008, The Journal of antimicrobial chemotherapy.

Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States

K. Krause, D. Sahm, C. Thornsberry, 2008, Antimicrobial Agents and Chemotherapy.

Bactericidal Activity and Resistance Development Profiling of Dalbavancin

B. Goldstein, D. Sahm, D. Sheehan, 2007, Antimicrobial Agents and Chemotherapy.

Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters.

D. Sahm, G. Moeck, F. Arhin, 2008, Diagnostic microbiology and infectious disease.

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy.

D. Nathwani, J. Karlowsky, D. Sahm, 2003, International journal of antimicrobial agents.

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Antimicrobial Agents and Chemotherapy.

Annals of Clinical Microbiology and Antimicrobials Open Access Emerging Resistance among Bacterial Pathogens in the Intensive Care Unit – a European and North American Surveillance Study (2000–2002) Intensive-care Unitantibiotic Susceptibility

R. Wenzel, J. Karlowsky, D. Sahm, 2022 .

Emergence of OXA-48-producing Enterobacteriaceae in Switzerland POTRON , Anaïs

F. Arhin, Deborah C. Draghi, C. Pillar, 2017 .

Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.

A. Evangelista, D. Sahm, C. Thornsberry, 2008, Postgraduate medicine.

Current antimicrobial resistance profiles among methicillin-resistant Staphylococcus aureus encountered in the outpatient setting.

D. Sahm, Deborah C. Draghi, P. Hogan, 2006, Diagnostic microbiology and infectious disease.

Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.

G. Tillotson, D. Sahm, I. Critchley, 2008, The Journal of antimicrobial chemotherapy.

Activity of cefditoren against beta-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis.

J. Karlowsky, D. Sahm, I. Critchley, 2002, Diagnostic microbiology and infectious disease.

Effect of Polysorbate-80 on Oritavancin Binding to Plastic Surfaces - 1

D. Sahm, G. Moeck, F. Arhin, 2008 .

In Vitro Activity of Linezolid against Key Gram-Positive Organisms Isolated in the United States: Results of the LEADER 2004 Surveillance Program

D. Sahm, D. Sheehan, Deborah C. Draghi, 2005, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Tigecycline against Gram-Positive and Gram-Negative Pathogens as Evaluated by Broth Microdilution and Etest (cid:1)

D. Sahm, Deborah C. Draghi, M. Dowzicky, 2008 .

Baseline in vitro Activity of Tigecycline among Key Bacterial Pathogens Exhibiting Multidrug Resistance

D. Sahm, Deborah C. Draghi, M. Dowzicky, 2008, Chemotherapy.

Annals of Clinical Microbiology and Antimicrobials Open Access Prevalence and Antimicrobial Susceptibilities of Bacteria Isolated from Blood Cultures of Hospitalized Patients in the United States in 2002

J. Karlowsky, D. Sahm, Mark E. Jones, 2022 .

Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004).

G. Tillotson, M. Jones, D. Sahm, 2006, International journal of antimicrobial agents.

Annals of Clinical Microbiology and Antimicrobials Prevalence of Antimicrobial Resistance in Bacteria Isolated from Central Nervous System Specimens as Reported by U.s. Hospital Laboratories from 2000 to 2002 Central Nervous System Infectionsmeningitisantibiotic Susceptibility

J. Karlowsky, Mark E. Jones, Deborah C. Draghi, 2022 .

R. Wenzel, J. Karlowsky, D. Sahm, 2022 .